Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
---|
08/11/2010 | CN101798383A Polymer microgel and preparation method thereof |
08/11/2010 | CN101797413A Drug carrier for nasal administration |
08/11/2010 | CN101797389A Method for preparing colon cancer chemotherapy medicament |
08/11/2010 | CN101797388A Matrix of suppository or paste medicine for treating prostatitis and preparation method thereof |
08/11/2010 | CN101797387A Magnetic targeting carrier capable of carrying gene and drug, preparation method and application thereof |
08/11/2010 | CN101797383A Hydro-acupuncture preparation of monoclonal antibody |
08/11/2010 | CN101797382A Anti-human progastrin polypeptide immune composition |
08/11/2010 | CN101797381A Compound of hepatitis B virus antigen and lewis oligosaccharide and preparation method and application thereof |
08/11/2010 | CN101797380A Method for preparing hogcholera vaccine |
08/11/2010 | CN101797304A Gel for adjusting microecology in vaginas of women |
08/11/2010 | CN101797278A Tripterygium wilfordii Hook.f total terpenoid vesicles and preparation method thereof |
08/11/2010 | CN101797269A Physiological balance liquid for adjusting microecology in vaginas of women |
08/11/2010 | CN101797268A Stable compound dimeticone hydrotalcite suspension |
08/11/2010 | CN101797264A Amphotericin B lipid complex for injection and preparation method thereof |
08/11/2010 | CN101797249A Medicinal composition containing pyridyl cyanoguanidine as well as preparation and application thereof |
08/11/2010 | CN101797244A Levodopa/benserazide orally disintegrating tablet |
08/11/2010 | CN101797241A Solid pharmaceutical compositions comprising a sip receptor agonist and a sugar alcohol |
08/11/2010 | CN101797239A Strychnos alkaloid vesicle and preparation method thereof |
08/11/2010 | CN101797238A Method for preparing medicinal preparation for releasing rifampicin on upper part of small intestine and characteristics of medicinal preparation |
08/11/2010 | CN101797236A Rivastigmine orally disintegration tablet and preparation method thereof |
08/11/2010 | CN101797234A Pramlintide acetate slow release microballoon preparation and preparation method thereof |
08/11/2010 | CN101797230A Liposome solid preparation of losartan potassium hydrochlorothiazide pharmaceutical composition |
08/11/2010 | CN101797229A Immune liposome based on Isthmin gene as well as preparation method and application thereof |
08/11/2010 | CN101797228A Method for preparing oryzanol microemulsion |
08/11/2010 | CN101797227A High oxidation resistance long chain fat emulsion injection and preparation method thereof |
08/11/2010 | CN101797226A High oxidation resistance medium/long chain fat emulsion injection and preparation method thereof |
08/11/2010 | CN101797225A High oxidation resistance long chain fat emulsion injection and preparation method thereof |
08/11/2010 | CN101797224A Breviscapinun nose drop and preparation method thereof |
08/11/2010 | CN101797223A Huperzine A preparations for eyes and application thereof |
08/11/2010 | CN101797222A Morphine sulfate sustained/controlled-release suppository and preparation method thereof |
08/11/2010 | CN101797221A Oral drug delivery system comprising high viscosity liquid carrier materials |
08/11/2010 | CN101797220A Oxaliplatin chitosan-stearic acid grafting micelle and application |
08/11/2010 | CN101797219A Solid sustained- release implant for curing esophageal carcinoma and preparation method thereof |
08/11/2010 | CN101797218A Prescription for preparing paracetamol freezable oral liquid |
08/11/2010 | CN101485673B Roxithromycin and ambroxol hydrochloride dispersible tablets |
08/11/2010 | CN101485447B Ferulaic acid cyclodextrin inclusion compound preparation method |
08/11/2010 | CN101485446B Preparation method of garlic oil cyclodextrin or cyclodextrin derivate inclusion compound |
08/11/2010 | CN101301476B Hydrophobic cyclodextrin clathrate and preparation and use thereof |
08/11/2010 | CN101259100B Etoposide preparations and preparation thereof |
08/11/2010 | CN101240030B Conjugate constructed from normal undecyl and RGD peptide, and its synthesis and application in medicine |
08/11/2010 | CN101240029B Conjugate constructed from normal heptyl and RGD peptide, and its synthesis method and application |
08/11/2010 | CN101156834B Ammonia temperature responsive form gel and its preparation method |
08/11/2010 | CN101103978B Berberine resin composition and its preparation method and medicinal composition containing the same |
08/11/2010 | CN101066267B Solid oral medicine composition containing aripiprazole microcrystal |
08/11/2010 | CN101036656B Stable cefoperazone tazobactam medicine compound preparation |
08/11/2010 | CN101012306B Collagen modified poly(3-hydroxybutyrate-3-hydroxyvalerate) and its preparing method and application |
08/11/2010 | CN101011409B Collunarium containing vitamin B12 |
08/11/2010 | CN100999546B Polypeptide compound with aza-containing heterocyclic modification and its application |
08/10/2010 | US7772352 drug delivery, tissue engineering, tissue adhesives, adhesion prevention,implantable medical devices, molded article; Paracetamol; moieties of glycolic acid, lactic acid, dioxanone, caprolactone; diisocyanate derivatives of phenolic drugs are polymer monomers |
08/10/2010 | US7772279 Use of vegetable butter-based cetyl myristoleate for treating osteoarthritis and other musculoskeletal disease conditions and injuries |
08/10/2010 | US7772252 Heterocyclic substituted carbonyl derivatives and their use as dopamine D3 receptor ligands |
08/10/2010 | US7771962 screening for a therapeutic oligopeptide for treatment of tumor disorders; contacting the tumor with a therapeutically effective amount of a CD10 cleavable prodrug, wherein tumor is comprised of one or more target cells which express CD10 for at least a portion of the target cell life cycle |
08/10/2010 | US7771748 Reducing smoking; side effect reduction |
08/10/2010 | US7771733 Compositions and methods for enhancing corticosteroid delivery |
08/10/2010 | US7771727 Conjugates of therapeutic or cytotoxic agents and biologically active peptides |
08/10/2010 | US7771710 Powdered polymer, method for its preparation, and use as a thickener |
08/10/2010 | US7770361 Powder compaction and enrobing |
08/10/2010 | CA2489325C Osmotic delivery system with early zero order push power engine comprising an osmotic agent dispersed in the fluid vehicle |
08/10/2010 | CA2471745C 25-hydroxy vitamin d3 compositions |
08/10/2010 | CA2459014C Amino acid modulated extended release dosage form |
08/10/2010 | CA2432175C Storage stable powder compositions of interleukin-4 receptor |
08/10/2010 | CA2413809C Synergistic antiplaque/antigingivitis oral composition |
08/10/2010 | CA2391832C Oral dosage forms |
08/10/2010 | CA2383493C Treating prostate cancer with anti-erbb2 antibodies |
08/10/2010 | CA2369457C Ocular treatment using cyclosporin-a derivatives |
08/10/2010 | CA2361238C Use of a melanoma inhibiting activity factor (mia) for cartilage and bone repair |
08/10/2010 | CA2359612C Food particulate |
08/05/2010 | WO2010088547A1 Assays for detecting pegylated blood coagulation factors |
08/05/2010 | WO2010088527A2 Peptides and nanoparticles for therapeutic and diagnostic applications |
08/05/2010 | WO2010088340A1 Oligomer-phenothiazine conjugates |
08/05/2010 | WO2010088336A1 Solid oral formulations of a pyridopyrimidinone |
08/05/2010 | WO2010088185A2 Matte skin finish compositions |
08/05/2010 | WO2010087462A1 Orally disintegrating tablet having inner core |
08/05/2010 | WO2010087447A1 Finely pulverized pharmaceutical composition |
08/05/2010 | WO2010087373A1 Method for producing extract of astaxanthin-containing yeast belonging to genus phaffia |
08/05/2010 | WO2010087358A1 Novel composition |
08/05/2010 | WO2010087032A1 Intraoral film-like base agent and formulation |
08/05/2010 | WO2010086989A1 Intraoral film-shaped base and preparation |
08/05/2010 | WO2010086985A1 Adsorbent for oral administration |
08/05/2010 | WO2010086880A2 A medical device loaded with formulations for targeted delivery of biologically active material/s and method of manufacture thereof |
08/05/2010 | WO2010086660A1 Apparatus, method and composition for topical treatment of warts and corns |
08/05/2010 | WO2010086637A1 Treatment of psoriasis |
08/05/2010 | WO2010086597A1 Delivery of nucleic acids using cell-penetrating peptides |
08/05/2010 | WO2010086441A1 Pharmaceutical composition comprising n-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine hydrochloride |
08/05/2010 | WO2010086401A1 Antibiotic peptides |
08/05/2010 | WO2010086129A1 Inclusion complex comprising cinacalcet and cyclodextrin |
08/05/2010 | WO2010053610A3 Stable anthrax vaccine formulations |
08/05/2010 | WO2010006194A3 Non-covalent modification of microparticles and process of preparing same |
08/05/2010 | US20100198210 Particles |
08/05/2010 | US20100197826 Wound Closing Compounds With Additives |
08/05/2010 | US20100197813 Heterocyclic Compounds as Sweetener Enhancers |
08/05/2010 | US20100197812 Compositions and methods for enhancing the stability of foods, beverages, nutritional supplements and cosmetics |
08/05/2010 | US20100197811 Aqueous composition |
08/05/2010 | US20100197810 Oil-in-water emulsions |
08/05/2010 | US20100197809 Skin solution and preparation method thereof |
08/05/2010 | US20100197808 Method for identifying mhc alleles in dogs |
08/05/2010 | US20100197806 Method Involving 1-Benzotriazolyl Carbonate Esters of Polymers |
08/05/2010 | US20100197805 Composition for improving the surface appearance of the skin |
08/05/2010 | US20100197804 Pharmaceutical compositions comprising terbinafine |
08/05/2010 | US20100197801 Volatile Distillate By-Product of Mint Oil That Promotes Absorption and/or Bioavailability of Compounds of Bio-Medical and Nutritional Interest |